Home » Topics » Articles » Insight

Insight
RSS

Public Financing Of Biotechnology: March 1998

April 6, 1998

Money Raised By Biotech In 1998: January - March

April 6, 1998

Other Financings Of Public Biotechnology Companies: March 1998

April 6, 1998

Venture Capital, PIPE/Reg. S, And Corporate Investments

April 6, 1998

Biotech Jumps On The Rollercoaster — Again

April 6, 1998

Gene Therapy Expertise Commands Attention Again

March 30, 1998

Biotech - Big Pharma Collaborations: New Agreements January 1998 - March 1998

March 30, 1998

bf03231998a.html

March 23, 1998

Sales Figures For Selected Biotech Drugs

March 23, 1998

FDA Submissions, Approvals And Other Actions: February 1998

March 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....